Co-Authors
This is a "connection" page, showing publications co-authored by Stefan Pöhlmann and Heike Hofmann-Winkler.
Connection Strength
2.268
-
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Rep. 2021 07 20; 36(3):109415.
Score: 0.238
-
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization. Cell Rep. 2021 04 20; 35(3):109017.
Score: 0.234
-
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021 04 29; 184(9):2384-2393.e12.
Score: 0.234
-
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine. 2021 Mar; 65:103255.
Score: 0.233
-
Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation. Crit Care Explor. 2020 Nov; 2(11):e0284.
Score: 0.228
-
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020 09; 585(7826):588-590.
Score: 0.223
-
Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. PLoS One. 2017; 12(6):e0179177.
Score: 0.180
-
TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells. PLoS One. 2015; 10(9):e0138380.
Score: 0.160
-
Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg Infect Dis. 2013 Dec; 19(12):2034-6.
Score: 0.141
-
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014 Jan; 88(2):1293-307.
Score: 0.141
-
TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol. 2013 Jun; 87(11):6150-60.
Score: 0.134
-
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination. Clin Infect Dis. 2021 12 06; 73(11):2000-2008.
Score: 0.061
-
Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study. Front Med (Lausanne). 2021; 8:644715.
Score: 0.059